Regulus Therapeutics Inc (RGLS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

4224 CAMPUS POINT COURT SAN DIEGO, CA 92121

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of microRNA therapeutics to treat a range of diseases primarily in the United States. The company is developing various oligonucleotides, including miR-21 for hepatocellular carcinoma and for kidney fibrosis, miR-122 for hepatitis C virus infection, miR-33 for atherosclerosis, and miR-10b for glioblastoma multiforme treatment.

Data as of 2021-05-08 11:17:20 -0400
Market Cap68.563 Million Shares Outstanding74.924 Million Avg 30-day Volume1.574 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.58 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.05468 52-week High/Low2.32 / 0.4222 Next Earnings Date2021-05-10 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from RGLS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 1 0.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 32 28 14.29% 11 (0.66%) 9 (0.56%) 22.22%
13F shares: 18.413 Million 7.815 Million 135.62% 9.018 Million 5.307 Million 69.95%
% Ownership 27.5229 19.9547 37.93% 13.4802 13.5499 -0.51%
New Positions: 11 2 450.0% 4 1 300.0%
Increased Positions 8 8 0.0% 3 1 200.0%
Closed Positions 7 9 -22.22% 2 4 -50.0%
Reduced Positions 3 4 -25.0% 1
Total Calls 173.65 Thousand 24.81 Thousand 599.92% 0 367 -100.0%
Total Puts 46.26 Thousand 31.039 Thousand 49.04%
PUT/CALL Ratio 0.27 1.25 -78.4% 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RGLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RGLS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HAGAN JOSEPH P PRESIDENT AND CEO

  • Officer
  • Director
320,478 2021-04-14 7

GROWTH EQUITY OPPORTUNITIES V, LLC

NEW ENTERPRISE ASSOCIATES 16, L.P.

NEA PARTNERS 16, L.P.

NEA 16 GP, LLC

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
0 2021-03-09 1

BASKETT FOREST

  • FORMER 10% OWNER
0 2021-03-09 2

FLORENCE ANTHONY A. JR.

  • FORMER 10% OWNER
0 2021-03-09 2

MAKHZOUMI MOHAMAD

  • FORMER 10% OWNER
0 2021-03-09 2

MAKOWER JOSHUA

  • FORMER 10% OWNER
0 2021-03-09 2

SANDELL SCOTT D

  • FORMER 10% OWNER
0 2021-03-09 2

SONSINI PETER W.

  • FORMER 10% OWNER
0 2021-03-09 2

BEHBAHANI ALI

  • FORMER 10% OWNER
0 2021-03-09 2

CHANG CARMEN

  • FORMER 10% OWNER
0 2021-03-09 2

WALKER PAUL EDWARD

  • FORMER 10% OWNER
0 2021-03-09 2

AKER CHRISTOPHER RAY SR. VP & GENERAL COUNSEL

  • Officer
42,614 2021-02-16 4

CALSADA CRISPINA CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-04 1

DRYGIN DENIS CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-02-04 3

HUANG ALICE SHIH-HOU

  • Director
25,604 2021-01-26 2

HUANG ALICE SHIH-HOU

BALTIMORE DAVID

  • Director
0 2021-01-06 2

PAPADOPOULOS STELIOS

  • Director
1,986,729 2020-12-04 3

BALTIMORE DAVID

  • Director
0 2020-06-17 1

RASTETTER WILLIAM H

  • Director
0 2020-06-17 1

ROSEN HUGH

  • Director
0 2020-06-17 1

WITZ PASCALE

  • Director
0 2020-06-17 1

COLLIER KATHRYN J

  • Director
0 2020-06-17 1

SIMEONIDIS SIMOS

  • Director
0 2020-06-17 1

NUNN JASON RALEIGH

  • Director
0 2020-06-17 1

SARISSA CAPITAL MASTER FUND II LP

  • 10% Owner
76,356 2020-04-01 0

SARISSA CAPITAL OFFSHORE MASTER FUND LP

  • 10% Owner
0 2020-04-01 0

BARRIS PETER J

  • 10% Owner
2,052,454 2019-12-24 0

MOTT DAVID M

  • 10% Owner
2,052,454 2019-12-24 0

DENNER ALEXANDER J

SARISSA CAPITAL MANAGEMENT LP

SARISSA CAPITAL OFFSHORE MASTER FUND LP

SARISSA CAPITAL CATAPULT FUND LLC

SARISSA CAPITAL HAWKEYE FUND LP

  • 10% Owner
0 2019-12-24 0

CHEVALLARD DANIEL R. CHIEF FINANCIAL OFFICER

  • Officer
77,870 2019-07-01 0

WRIGHT TIMOTHY MICHAEL CHIEF R & D OFFICER

  • Officer
62,893 2019-02-05 0

DEEG MARK ALBERT CHIEF MEDICAL OFFICER

  • Officer
0 2018-05-17 0

FOLETTA MARK G

  • Director
81,910 2017-12-04 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
11,108,515 2017-11-17 0

PUTTAGUNTA CHETAN

  • 10% Owner
10,989,010 2017-07-24 0

SAKODA JON

  • 10% Owner
10,989,010 2017-07-24 0

VISWANATHAN RAVI

  • 10% Owner
10,989,010 2017-07-24 0

GRINT PAUL C PRESIDENT & CEO

  • Officer
  • Director
0 2017-02-15 0

WILLIAMS DOUGLAS E

  • Director
0 2016-06-02 0

ALNYLAM PHARMACEUTICALS, INC.

  • 10% Owner
No longer subject to file 2016-02-23 0

ISIS PHARMACEUTICALS INC

  • 10% Owner
No longer subject to file 2015-07-15 0

CARTER BRUCE L A

  • Director
0 2015-06-10 0

XANTHOPOULOS KLEANTHIS G PRESIDENT AND CEO

  • Officer
  • Director
83,921 2015-04-17 0

GIBSON NEIL W CHIEF SCIENTIFIC OFFICER

  • Officer
0 2015-01-28 0

SZEKERES DAVID LESLIE CHIEF BUSINESS OFFICER & GC

  • Officer
0 2014-12-02 0

ASTRAZENECA PLC

ASTRAZENECA AB

  • 10% Owner
4,250,000 2014-11-12 0

ISIS PHARMACEUTICALS INC

PARSHALL B LYNNE

  • Director
  • 10% Owner
5,516,305 2014-11-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HAGAN JOSEPH P - Director - Officer PRESIDENT AND CEO

2021-04-16 16:12:40 -0400 2021-04-14 C 75,850 a 320,478 direct 0.0 18.6992 18.6992 6 -1.626 3

HAGAN JOSEPH P - Director - Officer PRESIDENT AND CEO pacific premier trust obo joseph p. hagan ira

2021-04-16 16:12:40 -0400 2021-04-14 C 7,585 a 0 indirect

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
REGULUS THERAPEUTICS INC RGLS 2021-05-14 22:15:03 UTC -10.4279 10.4779 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 21:45:03 UTC -10.4279 10.4779 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 21:15:03 UTC -10.4279 10.4779 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 20:45:03 UTC -10.4279 10.4779 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 20:15:04 UTC -10.4279 10.4779 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 19:45:02 UTC -10.4279 10.4779 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 19:15:03 UTC -10.4279 10.4779 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 18:45:03 UTC -10.4279 10.4779 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 18:15:03 UTC -10.4279 10.4779 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 17:45:03 UTC -10.4279 10.4779 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 17:15:03 UTC -10.4279 10.4779 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 16:45:03 UTC -10.4256 10.4756 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 16:15:03 UTC -10.4256 10.4756 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 15:45:03 UTC -10.4256 10.4756 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 15:15:02 UTC -10.4256 10.4756 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 14:45:04 UTC -10.1478 10.1978 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 14:15:03 UTC -10.1478 10.1978 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 13:45:03 UTC -10.1478 10.1978 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 13:15:03 UTC -10.1478 10.1978 300000
REGULUS THERAPEUTICS INC RGLS 2021-05-14 12:45:03 UTC -10.1478 10.1978 250000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC Regulus Therapeutics Inc 1.19% 2019-08-28 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 0.69% 2019-09-16 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 0.78% 2019-09-11 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 0.58% 2019-09-19 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 1.4% 2019-08-05 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 1.39% 2019-08-20 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 0.97% 2019-09-05 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 1.09% 2019-08-30 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 0.89% 2019-09-09 GERMANY
Squarepoint Ops LLC Regulus Therapeutics Inc 1.29% 2019-08-23 GERMANY

Elevate your investments